Express News | Viridian Therapeutics Inc - on Jan 7, Board Appoints Seth Harmon as CFO

Breakings05:22

Viridian Therapeutics: Strategic Positioning and First-Mover Advantage in the TED Market

TipRanksJan 9 15:25

Stifel Maintains Viridian Therapeutics(VRDN.US) With Buy Rating

Futu NewsJan 9 00:31 · Ratings

A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $38 to $48

Futu NewsJan 8 21:00 · Ratings

Expert Outlook: Viridian Therapeutics Through The Eyes Of 10 Analysts

BenzingaJan 7 22:00

Wedbush Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $48

Futu NewsJan 7 20:31 · Ratings